Safety and efficacy study of glucarpidase for delayed clearance of methotrexate after administration of high-dose methotrexate

Trial Profile

Safety and efficacy study of glucarpidase for delayed clearance of methotrexate after administration of high-dose methotrexate

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Glucarpidase (Primary)
  • Indications Chemotherapy-induced damage
  • Focus Pharmacokinetics
  • Acronyms CPG2-PII
  • Most Recent Events

    • 07 Jun 2016 Results (n=13) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 06 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top